患者:男,52岁 。临床表现:刺伤左手掌致疼痛、肿胀、活动受限5小时既往史:既往体健,无其它手术史及外伤史,无急慢性传染病史,无药物过敏史,无输血史。 体格检查:T36.5℃,P84次/分
Wang, PhD, MS1; Gowtham Asokan, MS2; Jukka-Pekka Onnela, DSc2; et alDonna D. Baird, PhD3; Anne
Jin, MD, MPH1; Ronilda Lacson, MD, PhD2; Mahsa Eskian, MD2; et alJulia McNabb-Baltar, MD, MPH1;
Yan, MD1; Yaoxian Yue, MD2; Yuzhou Guan, MD3; et alBitao Bu, MD4; Qing Ke, MD5; Ruisheng Duan, MD
既往的试验表明,与化学免疫治疗相比,不可逆 BTK 抑制剂伊布替尼(I)和BCL-2抑制剂维奈克拉(V)可改善 CLL 结局。I 和 V 靶向 CLL 的两个关键病理生理通路,具有协同作用。这得到
Bellai-Dussault, MSc1,2,3; Shelley D. Dougan, MSc2,3; Deshayne B. Fell, PhD1,3; et alJulian Little
Pellegrino, MD1,2; Patrizia Papacci, MD3,4; Flavia Beccia, MD3,4; et alFrancesca Serrao, MD3;
The Pros and Cons of Viral Testing: How to Risk- May 21, 2024Claire Castellano, MD, MPH, Pediatrics
A Randomized Clinical TrialDon Laing, MBChB1; Eamon P. G. Walsh, BMedSc1; Jane M. Alsweiler, PhD